Ovaprene could become the first FDA-approved monthly, self-administered, hormone-free contraceptive product
The opening marks the company's second location in Texas after Austin
Black women in the US experience maternal mortality two to three times higher than that of white women
A portion of Mommy Matters’ net proceeds will go to the global non-profit Saving Mothers
The American company specialises in fertility treatments, IVF, fertility testing and fertility preservation
Ovarian cancer is the second most common gynaecologic cancer in the US
ProgenyHealth highlights the need for fully integrated maternity programmes
Australia's Medical Research Future Fund provides grants to support medical research and innovation
Currently, there is no standard or routine screening test for thyroid cancer in the general population
The femtech start-up has announced an agreement with VGM & Associates
